Closing Bell: Market Post Declines For The 7th Straight Day; Sensex & Nifty Slide To 5-Month Lows; WHY?

The Indian stock market ended lower for the seventh consecutive session on November 18, marking its longest losing streak since February 2023. The Sensex declined 241 points to settle at 77,339, while the Nifty slipped 79 points to close at 23,454. Notably, the Nifty closed below its critical 200-day moving average of 23,556.

Broader markets, however, managed to outperform relatively. The Nifty Midcap index eked out a marginal gain of 2 points to close at 54,045, and the Nifty Bank index advanced by 184 points to 50,364, providing some respite amid the ongoing market weakness.

The trading session was marked by volatility, with sharp selling pressure observed in IT and metal stocks. The Nifty IT index emerged as the top loser, reflecting dampened investor sentiment following indications that a US Federal Reserve rate cut may not materialize soon.

Adding to the market's woes, heavyweight stocks such as Reliance Industries and ICICI Bank witnessed declines, further dragging the benchmarks. Reliance's dip was a significant factor in pushing the indices to levels last seen in late June.

On the other hand, auto stocks and HDFC Bank lent some support to the indices. However, their gains were insufficient to offset the overall bearish sentiment, leaving the market entrenched in its losing streak.

The metals sector saw a bright spot as stocks surged following China's announcement to scrap export tax rebates on certain products. This move is expected to reduce the global supply glut and support prices, benefiting Indian metal producers.

City gas distribution companies fell sharply, with stocks declining up to 20% after the government announced a second cut in APM gas allocations within a month. IT stocks continued their downtrend amid concerns over the Federal Reserve's monetary policy stance, which diminished hopes for a rate cut in the near term.

Muthoot Finance, Hero MotoCorp, and Crompton Greaves reacted positively to their earnings, gaining between 3% and 7%. IPCA Labs rose modestly, while Glenmark Pharmaceuticals declined sharply following management commentary that disappointed investors.

Honasa Consumer shares plunged 20% after the company posted a dismal set of earnings. Brainbees Solutions saw a 7% surge, buoyed by positive EBITDA results for Q2. Medplus Health Services rose 2% following a Rs 552 crore block deal, marking its fourth consecutive session of gains.

The market breadth remained skewed toward declines, with the advance-decline ratio standing at 1:2, indicating broad-based selling pressure. Despite some gains in select midcap and sectoral stocks, the overall sentiment remained cautious.

The Nifty's close below its 200-day moving average is a critical signal for traders and investors, suggesting potential for further downside. Analysts point to global headwinds, including the strong US Dollar and uncertainty over monetary policy, as factors contributing to the prolonged market weakness.